INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
HT

Horich William Todd

SVP, Commercial OperationsCIK 0002117599

EDGAR filingsOpen in network
Disclosed transactions27
Buys / sells0 / 2
Max Insider Score32
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
25.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    SUPERNUS PHARMACEUTICALS, INC.SVP, Commercial Operations · Mar 10, 2026
8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J
—
20.0K sh
Nov 2, 2026
Nov 4, 2026
traded Nov 2, 2026
+2d
SEC FORM 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
5,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,500 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
6,250 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
2,500 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,375 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
14.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
17.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
18.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
20.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
13.5K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
13.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
100.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

5
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Grant or award
A—
100.0K sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

20
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Tax withholding
F$67K
1,216 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

21
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
3,750 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

20
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Tax withholding
F$94K
1,718 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

13
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Tax withholding
F$29K
521 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

32
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Open-market sale
SELL$240K
4,438 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC FORM 4

Evidence

9
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
2,625 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

9
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
3,750 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

9
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
1,125 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

13
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
1,125 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

21
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
2,625 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

32
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Open-market sale
SELL$244K
4,439 sh
Mar 10, 2026Mar 10, 2026
traded Mar 10, 2026
+0dSEC FORM 4

Evidence